- Home
- CRBU vs STRS Comparison
CRBU vs STRS Comparison
Compare CRBU & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- STRS
- Stock Information
- Founded
- CRBU 2011
- STRS 1992
- Country
- CRBU United States
- STRS United States
- Employees
- CRBU N/A
- STRS N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- STRS Homebuilding
- Sector
- CRBU Health Care
- STRS Real Estate
- Exchange
- CRBU Nasdaq
- STRS Nasdaq
- Market Cap
- CRBU 236.3M
- STRS 202.0M
- IPO Year
- CRBU 2021
- STRS N/A
- Fundamental
- Price
- CRBU $2.68
- STRS $26.40
- Analyst Decision
- CRBU Strong Buy
- STRS
- Analyst Count
- CRBU 4
- STRS 0
- Target Price
- CRBU $14.00
- STRS N/A
- AVG Volume (30 Days)
- CRBU 1.5M
- STRS 8.4K
- Earning Date
- CRBU 11-06-2024
- STRS 11-15-2024
- Dividend Yield
- CRBU N/A
- STRS N/A
- EPS Growth
- CRBU N/A
- STRS N/A
- EPS
- CRBU N/A
- STRS N/A
- Revenue
- CRBU $11,475,000.00
- STRS $42,935,000.00
- Revenue This Year
- CRBU N/A
- STRS N/A
- Revenue Next Year
- CRBU $3.24
- STRS N/A
- P/E Ratio
- CRBU N/A
- STRS N/A
- Revenue Growth
- CRBU N/A
- STRS 31.68
- 52 Week Low
- CRBU $1.50
- STRS $20.30
- 52 Week High
- CRBU $8.33
- STRS $30.66
- Technical
- Relative Strength Index (RSI)
- CRBU 72.23
- STRS 60.21
- Support Level
- CRBU $2.37
- STRS $21.50
- Resistance Level
- CRBU $3.00
- STRS $27.77
- Average True Range (ATR)
- CRBU 0.23
- STRS 0.97
- MACD
- CRBU 0.09
- STRS 0.55
- Stochastic Oscillator
- CRBU 73.98
- STRS 78.15
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations.